Stock data
Heron Therapeutics, Inc. (HRTX)
Heron Therapeutics, Inc. (HRTX) reported net income of -US$20.20M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | US$113.56M | -US$2.54M | -US$20.20M | — |
| 2024 | — | US$105.64M | -US$11.53M | -US$13.58M | — |
| 2023 | — | US$61.94M | -US$110.61M | -US$110.56M | — |
| 2022 | — | US$52.80M | -US$174.66M | -US$182.02M | — |
| 2021 | — | — | -US$217.83M | -US$220.68M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$5.49M | — |
| 2026-03-31 | — | -US$8.11M | — |
| 2025-12-31 | — | -US$2.95M | — |
| 2025-09-30 | — | -US$17.50M | — |
| 2025-06-30 | — | -US$2.38M | — |
| 2025-03-31 | — | US$2.63M | — |
| 2024-12-31 | — | US$3.66M | — |
| 2024-09-30 | — | -US$4.85M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.